Enfusion, Inc. (ENFN)
After hours:
| Previous close | 9.77 |
| Open | 9.76 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 8.87 - 9.76 |
| 52-week range | 7.37 - 11.56 |
| Volume | |
| Avg. volume | 421,606 |
| Market cap | 887.868M |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | 132.29 |
| EPS (TTM) | 0.07 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 9.96 |
ZacksEnfusion (ENFN) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Enfusion (ENFN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Business Wire
Enfusion Announces First Quarter 2024 Results
NEW YORK & LONDON & HONG KONG, May 09, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its first quarter 2024 financial results as part of its 1Q 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com.
ZacksRadware (RDWR) Surpasses Q1 Earnings and Revenue Estimates
Radware (RDWR) delivered earnings and revenue surprises of 14.29% and 2.34%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
